ArticleOpen forum infectious diseases2025

To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?

Laurence Ollier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.